Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allo-HSCT for AML in Remission
NCT01020734Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- May 2011
- Primary completion
- Jul 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hematopoietic stem cells in acute myeloid leukemia (AML), sponsored by Asan Medical Center. Started May 2011; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01020734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01020734.